BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2005) 78, 686-693
© 2005 British Institute of Radiology
doi: 10.1259/bjr/26301414

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morcos, S K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morcos, S K

Review article

Acute serious and fatal reactions to contrast media: our current understanding

S K Morcos, FRCS, FRCR

Department of Diagnostic Imaging, Northern General Hospital, Sheffield Teaching Hospitals NHS Trust, Sheffield S5 7AU, UK

Serious or fatal reactions to a contrast medium (CM) are unpredictable but fortunately rare. History of serious reaction to CM, bronchial asthma or multiple allergies increases the incidence of serious reactions by a factor of 5. Serious or fatal reaction to CM could be due to direct effect on basophils and mast cells or IgE mediated (type 1 hypersensitivity reaction). Activation of the kinin system leading to the formation of bradykinin could also be involved. Complement activation is unlikely to be a primary factor in initiating a serious reaction to CM. Avoiding CM administration in patients at high risk of serious reaction is advisable, but if the administration is deemed essential all precautions should be implemented and measures to treat serious reactions should be readily available. Oxygen supplementation, intravenous administration of physiological fluids and intramuscular injection of 0.5 ml adrenalin (1:1000) should be considered in the first line management of acute anaphylaxis. The ability to assess and treat serious CM reaction effectively is an essential skill that the radiologist should have and maintain.




This article has been cited by other articles:


Home page
JAMAHome page
C. A. Herzog
Incidence of Adverse Events Associated With Use of Perflutren Contrast Agents for Echocardiography
JAMA, May 7, 2008; 299(17): 2023 - 2025.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. Trcka, C. Schmidt, C. S. Seitz, E.-B. Brocker, G. E. Gross, and A. Trautmann
Anaphylaxis to Iodinated Contrast Material: Nonallergic Hypersensitivity or IgE-Mediated Allergy?
Am. J. Roentgenol., March 1, 2008; 190(3): 666 - 670.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
G. Bierry, F. Kellner, C. Barnig, P. K. Woodard, L. R. Goodman, J. G. Weg, and P. D. Stein
Management of Patients with History of Adverse Effects to Contrast Media When Pulmonary Artery CT Angiography Is Required
Radiology, December 1, 2007; 245(3): 919 - 921.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2005 by the British Institute of Radiology.